Stay updated with breaking news from Release Tablets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cranford, N.J. -- Viona Pharmaceuticals Inc., is voluntarily recalling twenty-three (23) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg at the consumer level. Metformin Hydrochloride Extended-Release Tablets, USP 750
WASHINGTON (dpa-AFX) - Viona Pharmaceuticals Inc. is recalling twenty-three lots of type 2 diabetes drug Metformin Hydrochloride or HCI Extended-Release Tablets, USP 750 mg at the consumer level
/PRNewswire/ -- (Family Features) During this year's holidays, many families are looking forward to celebrating a closer-to-normal season. However, that means...
/PRNewswire/ -- (Family Features) During this year's holidays, many families are looking forward to celebrating a closer-to-normal season. However, that means...
richardApril 19, 2021 1 “On Nifedipine Market, Market Research Store published a report overview By Size, Industry leading Manufactures, Trends, Industry Growth Analysis & Forecast Till 2026” includes 190+ research pages PDF with TOC come up with a list of figures and tables. Market Research Store presents an latest and updated Study on Nifedipine Market 2021-2026. The report offers market prophesy related to market, revenue, Size, production, Consumption, CAGR, price, gross margin, and other major factors. While highlighting the important driving and preventing forces for this market...